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a b s t r a c t
This study was designed to assess the onset of therapeutic and residual insecticidal efﬁcacy of a topical
ectoparasiticide (Vectra®3D, DPP) on dogs over one month against the cat ﬂea, Ctenocephalides felis felis.
Adult dogs (n=32, 11.0–18.7 kg) were infested with 100 adult ﬂeas on days −6, −2, 7, 14, 21 and 28.
Based on ﬂea retention, the dogs were allocated in two groups and were treated topically on day 0
with a control solution (CS) or DPP. Each group was divided in two subgroups in which live ﬂeas were
counted by combing the dogs 2 or 6h after treatment and at each re-infestation. The insecticidal efﬁcacy
was calculated using arithmetic and geometric means at each time point. The ﬂea retention rate ranged
from 64.0 to 86.5% in the CS group throughout the study. Based on arithmetic means, the therapeutic
efﬁcacy was 96.4% 6h post-treatment and residual efﬁcacies ranged from 96.8 to 99.9% 2h after each
re-infestation. The residual speed of killing effectiveness, >96% at 2h, persisted for one month after
treatment. DPP administration was well tolerated. This study conﬁrms that DPP starts killing ﬂeas within
2h after treatment and reaches efﬁcacy levels >95% at 6h. We have shown that DPP kills >96.8% of ﬂeas
for one month after treatment within 2h after infestation.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Fleas are common hematophagous ectoparasites of dogs. The
cat ﬂea (Ctenocephalides felis felis) is the most frequent species
and represents a threat to both animal and human health because
of its bites and the risk of disease transmission. Fleas start their
ﬁrst blood meal shortly after invading the host (Varloud et al.,
2014) and perform numerous blood meals daily on the same host
but can accidentally infest humans. On human skin, each prob-
ing induces visible lesions and pruritic wheals that can occur in
clusters (Bitamet al., 2010). In dogs, ﬂea bites can induce hypersen-
sitivity reactions associated with typical dermatological conditions
(Bruet et al., 2012). C. felis is considered to be a vector of several
pathogens: viruses suchas calicivirus (Menckeet al., 2009), bacteria
such as Rickettsia felis (Capelli et al., 2009) and Bartonella (Bouhsira
et al., 2012), and helminths such as Dipylidium caninum (Hinaidy,
1991). Someof these organisms are zoonotic. Transmission of these
pathogens canoccur through ingestionof the infectiveﬂea, through
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blood feeding, and also by infective feces that can be ingested or
can contaminate a breach in the skin barrier. After the blood meal,
digestion starts immediately and the ﬂeas excrete their ﬁrst feces
approximately 30min after infestation (Wang et al., 2012). When
ﬂeas are infected with Bartonella, they can produce infective feces
for several days (Bouhsira et al., 2013; Kernif et al., 2014). Due to the
risks associated with ﬂea infestations, various ectoparasiticides are
available for the control and prevention of ﬂea infestations in dogs.
While the efﬁcacy of such products has been generally evaluated
48h after treatment of infestation, they are expected to act much
faster to relieve dogs from their ﬂeas, as well as to reduce the risks
of disease transmission. This studywas thereforedesigned to assess
the onset and residual performance 2 and 6h post-treatment and
after re-infestations over one month using a topical dinotefuran-
permethrin-pyriproxyfen combination (Vectra®3D) against adult
cat ﬂeas (C. felis) on dogs.
2. Materials and methods
The animals were not treated by any individual involved in
performing the post-treatment assessments and observations. Fur-
thermore, the study groups were coded to blind the assessors.
http://dx.doi.org/10.1016/j.vetpar.2015.05.005
0304-4017/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Table 1
Body weight and hair length of dogs.
Body weight (kg) Hair length (mm)
Group Mean Min Max Mean Min Max
CS 14.7 11.2 18.7 29.0 17.0 63.3
DPP 13.6 11.0 17.5 21.8 14.3 28.5
2.1. Dogs
Thirty-two healthy mongrel dogs (>6 months old, 1:1 sex ratio)
were enrolled in the study and completed an acclimation period of
at least 7 days. The dogs had not been treated with an acaricide or
insecticide for 12 weeks prior to day 0 of the study. All dogs were
identiﬁed with electronic transponders and were dewormed at the
beginning of the study. Their bodyweight (BW) ranged from11.0 to
18.7 kg and their hair length ranged from14 to63mm(Table 1). The
dogs were housed individually in an indoor animal unit that was
temperature controlled and set for a period of 12h light and 12h
darkness. The dogs were fed commercial dog food once daily with
water available ad libitum. No contact between dogs was possible
during the study. All dogs were observed for general health status
and adverse reactions to treatment once per day, from day −6 until
day 30, except on day 0, when a general examination, including
local tolerance assessments, was performed within 2h before and
1, 2 and 8h (±30min) post-treatment. This protocol was approved
by an independent animal ethics committee.
2.2. Allocation
The study followed a randomized block design. The 32 dogs
included were ranked, within gender, in descending order of indi-
vidual ﬂea counts on day −5. Within each gender, the animals were
assigned to blocks of four dogs each. Within each block, the dogs
were randomly allocated to groups 1 and 2, and in each group
the dogs were furthermore randomly assigned to one of two sub-
groups: a and b.
2.3. Treatment
Each dog was treated with the allocated treatment on day
0. Dogs in group 1 received the placebo control solution (CS)
containing the vehicle of the commercial formulation Vectra®3D
(Ceva Animal Health, Lenexa, KS, USA) with no active ingredient.
Dogs in group 2 were treated with the commercial formulation
Vectra®3D (DPP) containing the active ingredients dinotefuran
(4.95%), pyriproxifen (0.44%) and permethrin (36.08%). Both treat-
ments were administered topically, as spot-on, according to the
manufacturer’s label directions, at a rate of 3.6mL per dog applied
equally (1.2mL per site) in three spots at the shoulder blades, the
mid-back and the base of the tail (Table 2).
2.4. Flea infestations
A laboratory-bred strain of C. felis felis was used for the experi-
mental infestation. Fleas were routinely fed on cats. Each dog was
infested with 100 adult ﬂeas on days −6, −2, 7, 14, 21 and 28. The
ﬂeas were unfed and of mixed sex.
Flea countswere conducted by combing and removing the para-
sites on the dogs at 2±0.5h in the ﬁrst subgroup (a) and at 6±0.5h
post-infestation or treatment in the second subgroup (b).
2.5. Statistical analysis
The calculations were based on the geometric means of the
ﬂea (count +1) data. One (1) was subsequently subtracted from
the result to obtain a meaningful value for the geometric mean
of the study groups. Arithmetic means and efﬁcacies based on the
arithmetic means were also calculated.
The percent efﬁcacy for each subgroup (a, 2h or b, 6h) on each
day was calculated as:
Efﬁcacy (%) = 100 × (MC − MT)
MC
where MC is the mean (geometric or arithmetic) of live ﬂeas in the
CS group and MT is the mean (geometric or arithmetic) of the live
ﬂeas in the treated group.
The groups were compared using analysis of variance (ANOVA)
with a treatment effect after a logarithmic transformation of the
(ﬂea count +1) data. Statistical signiﬁcance was declared at a two-
sided p-value of 0.05.
2.6. Guidelines
The study was conducted in accordance with the current and
appropriate guidelines (CVMP, 2000, 2007).
3. Results
The study was run in October and November; this time period
corresponds to the end of spring and the beginning of summer in
South Africa. The temperature inside the housing unit remained
between 17.0 and 26.4 ◦C and the recorded relative humidity
ranged from 19.9 to 79.0%.
No adverse effects were observed in any of the treated dogs.
Cosmetic effects, described as the “spiking with a wet paint brush
effect”, were noticed on all dogs 1–8h after administration of the
treatment.
In the CS group, the average ﬂea retention rate in the subgroups
collected 2 and 6h post-treatment was 64.8% and 64.0%, respec-
tively (Table 3). There were from 28 to 94 live ﬂeas on each dog
in the CS group. Two hours after the administration of DPP, one
dog was free of ﬂeas. The insecticidal efﬁcacy based on arithmetic
means was 23.0%. The number of live ﬂeas found on dogs ranged
Table 2
Concentrations of active ingredients delivered individually in each subgroup on day 0.
Subgroup Active ingredient mg/kg BWa mg/m2 BSAb
Mean Min Max Mean Min Max
2h Dinotefuran 14.9 11.2 17.9 313.4 291.1 345.5
Pyriproxyfen 1.3 1.0 1.6 27.9 25.9 30.7
Permethrin 108.3 81.5 130.1 2284.5 2121.8 2518.2
6h Dinotefuran 14.5 12.7 17.8 320.6 266.2 375.8
Pyriproxyfen 1.3 1.1 1.6 28.5 23.7 33.4
Permethrin 105.6 92.9 129.7 2336.8 1940.4 2739.5
a BW: body weight.
b BSA: body surface area.
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Table 3
Flea counts and efﬁcacy 2 and 6h. after treatment and weekly (days −2, 7, 14, 21 and 28) infestations with adult C. felis on dogs treated with a control (CS) or a topical
ectoparasiticide (DPP) on day 0.
Days 0 7 14 21 28
Mean AMb GM AM GM AM GM AM GM AM GM
CSa 2h 64.8 62.0 85.9 85.6 76.9 76.4 78.1 77.2 86.5 86.2
DPP 2h 49.9 26.6 0.4 0.3* 0.4 0.3* 0.1 0.1* 2.8 2.0*
Efﬁcacy (%) 23.0 57.1 99.5 99.7 99.5 99.7 99.9 99.9 96.8 97.7
FF 2h (n) 1/8 5/8 6/8 7/8 2/8
CS 6h 64.0 60.7 68.0 65.3 64.1 62.8 67.9 66.1 73.0 70.4
DPP 6h 2.3 1.7 0.0 0.0* 0.0 0.0* 0.0 0.0* 1.0 0.5*
Efﬁcacy (%) 96.4 97.2 100 100 100 100 100 100 98.6 99.3
FF 6h (n) 2/8 8/8 8/8 8/8 6/8
a CS: control solution; DPP: dinotefuran, pyriproxyfen, permethrin; FF: number of dogs free of live ﬂeas.
b AM: arithmetic mean; GM: geometric mean.
*Group differed (p<0.05) within each time point.
between 0 and 93. Six hours after the administration of DPP, two
dogs were free of ﬂeas. The number of live ﬂeas found on the dogs
ranged from 0 to 5. The insecticidal efﬁcacy based on arithmetic
means was 96.5%.
In the CS group, the average ﬂea retention rate observed in
weekly re-infestations ranged from 64.1 to 86.5% (Table 3). In the
ﬁrst DPP-treated subgroup, there were from 0 to 6 live ﬂeas found
on the dogs 2h after infestation. The insecticidal efﬁcacy based on
arithmetic means was above 99% for 3 weeks post-treatment and
was 96.8% during the fourth week. In the second subgroup, there
were from 0 to 5 live ﬂeas found on DPP-treated dogs 6h after
infestation. The insecticidal efﬁcacybasedonarithmeticmeanswas
100% for 3 weeks post-treatment and was 98.6% during the fourth
week. All DPP-treated dogs from subgroup b were free of ﬂeas at
every time point, except for 2 dogs during the fourth week.
4. Discussion
As demonstrated in the CS group, which was characterized by
an average ﬂea retention rate of 72.2%, the ﬂea challenges were
vigorous during the entire duration of the study.
4.1. Therapeutic efﬁcacy
In this study, the therapeutic efﬁcacy was measured 2 and 6h
after the administration of the products on dogs already infested
with ﬂeas for 2 days. Although the active ingredients needed time
to spread over the body surface and coat to reach the most distal
parts of the animal where ﬂeas could hide, 1 out of the 8 dogs was
already ﬂea-free 2h after treatment in subgroup a and the insec-
ticidal efﬁcacy reached 96.4% 6h after treatment in subgroup b.
These results conﬁrmed previous evaluations of the therapeutic
efﬁcacy of DPP against ﬂea infestations in dogs that were also mea-
sured 6h after treatment (97.2%) but using a different strain of ﬂeas
(Dryden et al., 2011). Although the therapeutic speed of kill is often
considered to be a marker of the parasiticide performance, it has
less clinical relevance compared with the residual speed of kill. The
therapeutic speed of kill occurs only on the day of treatment for a
dog already infested for an undetermined length of time while the
residual speedof kill is linked to thedurationofprotectionexpected
from the product.
4.2. Residual efﬁcacy
From days 7 to 28, based on arithmetic means, DPP killed >96.8
% of ﬂeas in 2h after each infestation. There were no ﬂeas found on
dogs 6h after infestation from days 7 to 21 and efﬁcacy on day 28
was 98.6%. Such results conﬁrm the residual speed of kill perfor-
mance of DPP against ﬂeas that was already evaluated 6 and 24h
after weekly re-infestations (Dryden et al., 2011). The residual efﬁ-
cacy was assessed weekly in situations in which the parasites must
enter the coat of the dogs and move on each animal’s skin up to
their location for feeding, increasing both their level of metabolism
and their exposure to already-treated skin and hair. However, in
such circumstances, the concentration of active ingredients in the
animals often follows a decay-curve pattern. This factwas observed
with topical administrationsofpermethrin (Lüssenhopet al., 2011),
imidacloprid (Chopade et al., 2010) and ﬁpronil (Bigelow Dyk et al.,
2012), andwith oral administrations of spinosad (Holmstrom et al.,
2011) and afoxolaner (Letendre et al., 2014). The decrease in con-
centration of active ingredients can be due to different factors such
as formulation (Endris et al., 2003),metabolism, hair loss and expo-
sure to sunlight or water. The efﬁcacy level can be maintained
at the required threshold until the next administration when the
assessments are performed 48h after re-infestations while it is less
common for the speed of kill. Indeed, for example with spinosad,
the efﬁcacy measured at 4h against C. canis can decrease from 81%
on the day of treatment to 42% on day 28 after the treatment (Franc
and Bouhsira 2009). On the other hand, the DPP formulation pro-
vides a high and residual speed of kill, effective against new ﬂea
infestations for one month after administration. These aspects of
DPP should be explored to preventively protect against ﬂea bites
and ﬂea-borne diseases.
4. Conclusion
This experiment has demonstrated that DPP not only starts
killing a signiﬁcant number of ﬂeas within 2h after treatment but
also relieves dogs of almost all ﬂeas in 6h. DPP also provides protec-
tion against ﬂea infestations that lasts for amonth, as demonstrated
by the high (>96.8%) residual insecticidal efﬁcacy within 2h after
infestation at every time point for one month. Although further
investigations should be performed to determine the performance
of DPP over shorter time intervals after ﬂea infestations, this com-
bination should be considered as a reliable veterinary prevention
tool to protect dogs against infestations by the cat ﬂea C. felis.
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